Ikarian Capital’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-206,336
| Closed | -$259K | – | 188 |
|
2022
Q1 | $259K | Buy |
206,336
+9,515
| +5% | +$11.9K | 0.03% | 120 |
|
2021
Q4 | $228K | Hold |
196,821
| – | – | 0.03% | 120 |
|
2021
Q3 | $377K | Sell |
196,821
-3,179
| -2% | -$6.09K | 0.03% | 128 |
|
2021
Q2 | $468K | Buy |
200,000
+121,233
| +154% | +$284K | 0.04% | 136 |
|
2021
Q1 | $213K | Buy |
+78,767
| New | +$213K | 0.01% | 160 |
|